The efficacy and safety of sitagliptin administration in patients with Covid-19: A randomized clinical trial
Background: Coronavirus disease was associated with a high risk of mortality, especially among patients with underlying diseases.Effective treatments against Covid-19 could complement vaccination efforts worldwide.Methods: To determine the efficacy of Sitagliptin in the treatment of COVID-19.Randomized clinical trial study with a control group that